Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
Study NCT ID:
NCT00464308
Status:
COMPLETED
Last Update Posted:
2014-04-21
First Post:
2007-04-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg
Sponsor:
Janssen-Cilag Pty Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-20
First Submit QC Date:
None
Study First Post Date:
2007-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-06-09
Results First Submit QC Date:
None
Results First Post Date:
2010-08-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-02
Last Update Post Date:
2014-04-21
Last Update Post Date Type:
ESTIMATED